logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Junxin Wu

fujian medical university
H指数:24
被引数:1,791

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Survival benefit of adjuvant radiotherapy following asparaginase-based chemotherapy in patients with chemo-responsive advanced-stage extranodal NK/T-cell lymphoma: A multicenter study using the CLCG database

异位NK/T细胞淋巴瘤患者对化疗有反应的晚期阶段中，辅助放疗在基于门冬酰胺酶的化疗后的生存获益：一项使用CLCG数据库的多中心研究

international journal of radiation oncology biology physics
IF0
2025-09-170
PRE
Ke Su; Xiao-Rong Hou; Qiu-Zi Zhong; Xin Liu; Li-Ting Qian; Xue-Ying Qiao; Hua Wang; Yuan Zhu; Jian-Zhong Cao; Jun-Xin Wu; Tao Wu; Su-Yu Zhu; Mei Shi; Hui-Lai Zhang; Xi-Mei Zhang; Hang Su; Yu-Qin Song; Jun Zhu; Yu-Jing Zhang; Hui-Qiang Huang; Ying Wang; Xia He; Li-Ling Zhang; Bao-Lin Qu; Yong Yang; Shu-Lian Wang; Shu-Nan Qi; Ye-Xiong Li
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial

根据UGT1A1状态指导的卡培他滨联合伊立替康新辅助放化疗在局部晚期直肠癌患者中的应用：CinClare试验5年更新

Cancer Communications
IF24.9
2025-09-030
OAAI
Zhen Zhang; Xinchen Sun; Anwen Liu; Yaqun Zhu; Tao Zhang; Luying Liu; Jianhui Jia; Shisheng Tan; Junxin Wu; Xin Wang; Juying Zhou; Jialin Yang; Chen Zhang; Hongyan Zhang; Xinjia He; Gang Cai; Chengyi Huang; Fan Xia; Juefeng Wan; Hui Zhang; Lijun Shen; Ling Wang; Wei Zhang; Sanjun Cai; Ji Zhu
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-10-010
OAAI
Luo, Fei; Zhong, Qiu-Zi; Liu, Xin; Hou, Xiao-Rong; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

来自CLCG研究的结外自然杀伤/T细胞淋巴瘤患者早期进展的结果和风险预测

ANNALS OF HEMATOLOGY
IF2.4
2023-06-120
OAAI
Li, Jia-Ying; Hou, Xiao-Rong; Chen, Si-Ye; Liu, Xin; Zhong, Qiu-Zi; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
HAEMATOLOGICA
IF7.9
2023-03-237
OAAI
Liu, Xin; Zhang, Li-Ling; Qu, Bao-Lin; Zhong, Qiu-Zi; Qian, Li-Ting; Yang, Yong; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; Chen, Fan; Yin, Lin; He, Xia; Cai, Shang; Li, Ye-Xiong; Qi, Shu-Nan

研究方向

暂未获取到该数据
L
Lingdong Shao
H 指数:11论文数:39被引数:376
Y
Yuan Zhu
H 指数:30论文数:164被引数:3,084
吴
吴涛
H 指数:42论文数:198被引数:6,196
X
Xiaorong Hou
H 指数:22论文数:173被引数:1,599
H
Hang Su
H 指数:27论文数:269被引数:2,362
X
Xia He
H 指数:57论文数:374被引数:1.1万
B
Baolin Qu
H 指数:20论文数:155被引数:1,400
Y
Ye‐Xiong Li
H 指数:47论文数:540被引数:1.0万
X
Xueying Qiao
H 指数:14论文数:125被引数:935
L
Liting Qian
H 指数:20论文数:104被引数:1,401